T
Tenax Therapeutics, Inc. (TENX)
NCM – Real vaqt narxi. Valyuta: USD
12.17
+0.22 (1.84%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
12.17
+0.22 (1.84%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Tenax Therapeutics, Inc., rivojlanish bosqichidagi farmatsevtika kompaniyasi, Qo'shma Shtatlarda yangi kardiopulmoner terapiyalarni ishlab chiqadi. U yurak etishmovchiligi bilan saqlanib qolgan ejeksiyon fraktsiyasi va tegishli o'pka gipertenziyasi bo'lgan bemorlarni davolash uchun II bosqich klinik sinovlarini yakunlagan TNX-101, TNX-102 va TNX-103 (levosimendan) ni ishlab chiqadi; va surunkali miyeloid leykemiyani davolash uchun tirozin kinaz inhibitori bo'lgan TNX-201 (imatinib). Kompaniya ilgari Oxygen Biotherapeutics, Inc. nomi bilan tanilgan va 2014-yil sentyabr oyida Tenax Therapeutics, Inc. nomini olgan. Tenax Therapeutics, Inc. 1967-yilda tashkil etilgan va shtab-kvartirasi Shimoliy Karolina shtatining Chapel Hill shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Douglas Hay Ph.D. | Executive Vice President of Regulatory Affairs |
| Dr. Stuart Rich M.D. | Chief Medical Officer & Director |
| Mr. Christopher T. Giordano | CEO, President & Director |
| Mr. Doug Randall | Chief Business Officer |
| Mr. Thomas A. McGauley | Interim CFO and Principal Financial Officer & Principal Accounting Officer |
| Mr. Timothy G. Healey M.B.A. | Chief Commercial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-12 | S-8 | d265269ds8.htm |
| 2026-04-22 | DEF 14A | tennx-20260417.htm |
| 2026-04-22 | 8-K | d81080d8k.htm |
| 2026-03-31 | CORRESP | filename1.htm |
| 2026-03-24 | S-3 | tennx_s3.htm |
| 2026-03-10 | 8-K | tennx_8k.htm |
| 2026-01-09 | 8-K | tennx_8k.htm |
| 2025-12-17 | 8-K | tennx_8k.htm |
| 2025-11-12 | 8-K | tennx_8k.htm |
| 2025-09-16 | 8-K | tennx_8k.htm |